Purchases and Sales Made in Q3 2023 in Rocket Pharmaceuticals, Inc. (RCKT)
This table provides information about the institutional ownership of Rocket Pharmaceuticals, Inc. (RCKT) during Q3 2023. The information is specifically focused on institutions that hold shares of ROCKET PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 13, 2023
Q3 2023
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-103K- 65.67% |
$1.55M - $2.48M
|
53.9K
$561K
|
|
|
Nov 13, 2023
Q3 2023
|
M28 Capital Management LP
Stamford, CT |
SELL
|
- |
-107K- 16.99% |
$1.61M - $2.58M
|
523K
$5.45M
|
|
|
Nov 13, 2023
Q3 2023
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-140K- 52.46% |
$2.11M - $3.37M
|
127K
$1.32M
|
|
|
Nov 13, 2023
Q3 2023
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-321KClosed |
$4.83M - $7.71M
|
0
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-419K- 48.19% |
$6.31M - $10.1M
|
450K
$4.68M
|
|
|
Nov 14, 2023
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-911K- 63.24% |
$13.7M - $21.9M
|
530K
$5.51M
|